F40.00 F43.1 F40.1 F40.2 F40.8 F41.1
Conditions
Interventions
Group 1: Part A: intervention group: CBM-I for anxiety disorder.
Waiting list control group: TAU. Upon study completing patients within the WL group will be able to access the CBM-I training.
Group 2:
Sponsors
Klinikum ChristophsbadChristophsbad Akademie für Psychotherapie (C-AP)Forschungssektion für Angewandte Psychotherapie und Psychiatrie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosis of anxiety disorder or phobic disorder (Study A); Diagnosis of post-traumatic stress disorder (Study B); healthy subjects or subjects with anxiety disorder (Study C); healthy subjects or subjects with post-traumatic stress disorder (Study D). Required age of 18years old. German fluent in word an writing.
Exclusion criteria
Exclusion criteria: Ongoing psychotherapy, acute psychopharmacological emercency medication, severe comorbid disorders from the schizophrenic spectrum and bipolar-affective disorders, acute suicidality, addiction disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of interpretation biases (A&B): AST-D-II, wSST, trSST) 4 measurement time-points: T1 (Baseline), T2 (Post-Measurement 1 week after 3-week intervention), T3 (Follow-Up Measurement 2 months after 3-week intervention), T4 (Follow-up Measurement 1 week after booster week). | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of anxiety/worry symptoms (A). Improvement of PTSD symptoms (B). T1-T4: Study (A) STAI, PSWQ-d; Study (B) PTCI, PCL-5. Study A&B: Negative affectivity: T1-T4: BDI-II | — |
Countries
Germany
Contacts
Public ContactSandra Scholl
Forschungssektion für angewandte Psychotherapie und Psychiatrie
Outcome results
None listed